Parvaneh Mehrbod1, Sana Eybpoosh2, Behrokh Farahmand3, Fatemeh Fotouhi3, Majid Khanzadeh Alishahi4. 1. Influenza and Respiratory Viruses Department, Pasteur Institute of Iran, Tehran, Iran. mehrbode@yahoo.com. 2. Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran. 3. Influenza and Respiratory Viruses Department, Pasteur Institute of Iran, Tehran, Iran. 4. Private Practitioner, Mashhad, Iran.
Abstract
BACKGROUND: Variation in host genetic factors may result in variation in the host immune response to the infection. Some chronic diseases may also affect individuals' susceptibility to infectious diseases. The aim of this study was to evaluate the association of the host genetic factors mostly involved in inflammation, as well as hypercholesterolemia and diabetes with mild flu in an Iranian population. METHODS: In this cross-sectional study, nasopharyngeal swab samples were collected from 93 patients referred to primary care centers of Markazi, Semnan, and Zanjan provinces (central Iran) due to flu-like symptoms between March 2015 and December 2018. Of these, PCR test identified 49 influenza A/H1N1 and 44 flu-negative individuals. Twelve single-nucleotide polymorphisms (SNPs) in RPAIN, FCGR2A, MBL-2, CD55, C1QBP, IL-10, TNF-α and an unknown gene were genotyped using iPLEX GOLD SNP genotyping analysis. Hypercholesterolemia and diabetes status was determined based on the physician diagnosis. Association of the host genetic variants, hypercholesterolemia and diabetes with mild A/H1N1 flu was assessed with univariable and multivariable logistic regression analysis as implemented in Stata software (v.14). Statistical tests were considered as significant at 0.05 levels. RESULTS: Frequency of diabetes and hypercholesterolemia, as well as participants mean age was significantly higher in the flu-negative rather than the flu-positive group. Of 12 SNPs, nine did not show any significant association with mild flu in our study (rs1801274, rs1800451, rs2564978, rs361525, rs1800450, rs1800871, rs1800872, rs1800896, rs1800629). Possessing G vs. A allele in two SNPs (rs3786054 and rs8070740) was associated with a threefold increase in the chance of mild flu when compared to flu-negative patients (95% CI: 1.1, 22.0). Possessing C allele (vs. A) in the rs9856661 locus also increased the chance of mild flu up to 2 folds (95% CI: 1.0, 10.0). CONCLUSION: The results showed that possessing the G allele in either rs3786054 or rs8070740 loci in C1QBP and RPAIN genes, respectively, increased the risk of H1N1 infection up to 3.3 folds, regardless of the patient's age, BMI, diabetes, and hypercholesterolemia. Complementary functional genomic studies would shed more light on the underlying mechanism of human immunity associated with these genetic markers. The identified genetic factors may have the same role in susceptibility to similar respiratory infections with RNA viruses, like SARS, MERS and COVID-19. Future genetic association studies targeting these RNA viruses, especially COVID-19 is recommended. Studies on other ethnic groups would also shed light on possible ethnic variations in genetic susceptibility to respiratory RNA viruses. Trial registry IR.PII.REC.1399.063.
BACKGROUND: Variation in host genetic factors may result in variation in the host immune response to the infection. Some chronic diseases may also affect individuals' susceptibility to infectious diseases. The aim of this study was to evaluate the association of the host genetic factors mostly involved in inflammation, as well as hypercholesterolemia and diabetes with mild flu in an Iranian population. METHODS: In this cross-sectional study, nasopharyngeal swab samples were collected from 93 patients referred to primary care centers of Markazi, Semnan, and Zanjan provinces (central Iran) due to flu-like symptoms between March 2015 and December 2018. Of these, PCR test identified 49 influenza A/H1N1 and 44 flu-negative individuals. Twelve single-nucleotide polymorphisms (SNPs) in RPAIN, FCGR2A, MBL-2, CD55, C1QBP, IL-10, TNF-α and an unknown gene were genotyped using iPLEX GOLD SNP genotyping analysis. Hypercholesterolemia and diabetes status was determined based on the physician diagnosis. Association of the host genetic variants, hypercholesterolemia and diabetes with mild A/H1N1 flu was assessed with univariable and multivariable logistic regression analysis as implemented in Stata software (v.14). Statistical tests were considered as significant at 0.05 levels. RESULTS: Frequency of diabetes and hypercholesterolemia, as well as participants mean age was significantly higher in the flu-negative rather than the flu-positive group. Of 12 SNPs, nine did not show any significant association with mild flu in our study (rs1801274, rs1800451, rs2564978, rs361525, rs1800450, rs1800871, rs1800872, rs1800896, rs1800629). Possessing G vs. A allele in two SNPs (rs3786054 and rs8070740) was associated with a threefold increase in the chance of mild flu when compared to flu-negative patients (95% CI: 1.1, 22.0). Possessing C allele (vs. A) in the rs9856661 locus also increased the chance of mild flu up to 2 folds (95% CI: 1.0, 10.0). CONCLUSION: The results showed that possessing the G allele in either rs3786054 or rs8070740 loci in C1QBP and RPAIN genes, respectively, increased the risk of H1N1infection up to 3.3 folds, regardless of the patient's age, BMI, diabetes, and hypercholesterolemia. Complementary functional genomic studies would shed more light on the underlying mechanism of human immunity associated with these genetic markers. The identified genetic factors may have the same role in susceptibility to similar respiratory infections with RNA viruses, like SARS, MERS and COVID-19. Future genetic association studies targeting these RNA viruses, especially COVID-19 is recommended. Studies on other ethnic groups would also shed light on possible ethnic variations in genetic susceptibility to respiratory RNA viruses. Trial registry IR.PII.REC.1399.063.
Authors: Jill M Ferdinands; Amy M Denison; Nicole F Dowling; Heather A Jost; Marta L Gwinn; Lindy Liu; Sherif R Zaki; David K Shay Journal: Emerg Infect Dis Date: 2011-12 Impact factor: 6.883
Authors: I-Chueh Huang; Charles C Bailey; Jessica L Weyer; Sheli R Radoshitzky; Michelle M Becker; Jessica J Chiang; Abraham L Brass; Asim A Ahmed; Xiaoli Chi; Lian Dong; Lindsay E Longobardi; Dutch Boltz; Jens H Kuhn; Stephen J Elledge; Sina Bavari; Mark R Denison; Hyeryun Choe; Michael Farzan Journal: PLoS Pathog Date: 2011-01-06 Impact factor: 6.823
Authors: Jesus F Bermejo-Martin; Ignacio Martin-Loeches; Jordi Rello; Andres Antón; Raquel Almansa; Luoling Xu; Guillermo Lopez-Campos; Tomás Pumarola; Longsi Ran; Paula Ramirez; David Banner; Derek Cheuk Ng; Lorenzo Socias; Ana Loza; David Andaluz; Enrique Maravi; Maria J Gómez-Sánchez; Mónica Gordón; Maria C Gallegos; Victoria Fernandez; Sara Aldunate; Cristobal León; Pedro Merino; Jesús Blanco; Fernando Martin-Sanchez; Lucia Rico; David Varillas; Veronica Iglesias; Maria Ángeles Marcos; Francisco Gandía; Felipe Bobillo; Begoña Nogueira; Silvia Rojo; Salvador Resino; Carmen Castro; Raul Ortiz de Lejarazu; David Kelvin Journal: Crit Care Date: 2010-09-14 Impact factor: 9.097
Authors: Román Alejandro García-Ramírez; Alejandra Ramírez-Venegas; Roger Quintana-Carrillo; Ángel Eduardo Camarena; Ramcés Falfán-Valencia; Juan Manuel Mejía-Aranguré Journal: PLoS One Date: 2015-12-14 Impact factor: 3.240
Authors: Nelson Lee; Bin Cao; Changwen Ke; Hongzhou Lu; Yunwen Hu; Claudia Ha Ting Tam; Ronald Ching Wan Ma; Dawei Guan; Zhaoqin Zhu; Hui Li; Mulei Lin; Rity Y K Wong; Irene M H Yung; Tin-Nok Hung; Kirsty Kwok; Peter Horby; David Shu Cheong Hui; Martin Chi Wai Chan; Paul Kay Sheung Chan Journal: J Infect Dis Date: 2017-07-01 Impact factor: 5.226
Authors: Fani Chatzopoulou; Georgia Gioula; Ioannis Kioumis; Dimitris Chatzidimitriou; Maria Exindari Journal: Med Microbiol Immunol Date: 2018-10-10 Impact factor: 3.402